---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-020150"
form_type: "8-K"
ticker: "BFRG"
cik: "0001829247"
company_name: "BullFrog AI Holdings, Inc."
filed_at: "2024-05-16T23:59:59+00:00"
generated_at: "2026-06-01T21:39:41.078589+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Bullfrog AI and Lieber Institute identify novel drug targets for neuropsychiatric disorders

## Summary
- Identified dozens of patient clusters for depression, schizophrenia, and bipolar disorder using bfLEAP AI platform.
- Key genes pinpointed for each cluster as potential drug targets; now applying Causal AI for validation.
- Engagement initiated with pharmaceutical companies to secure strategic partnerships in coming quarters.
- Collaboration leverages LIBD's brain data from over 2,800 samples under a three-year exclusive agreement.
- Findings build on September 2023 partnership and January 2024 stratification results.

## SEC filing metadata
- accession: 0001493152-24-020150
- form_type: 8-K
- ticker: BFRG
- cik: 0001829247
- company_name: BullFrog AI Holdings, Inc.
- filed_at: 2024-05-16T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1829247/000149315224020150/0001493152-24-020150-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1829247/000149315224020150/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-020150
- JSON: https://secwatch.observer/filing/0001493152-24-020150.json
- Plain text: https://secwatch.observer/filing/0001493152-24-020150.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.